NASDAQ:SDGR
Schrodinger Inc. Stock News
$22.76
-0.140 (-0.611%)
At Close: May 17, 2024
Schrodinger (SDGR) to Report Q1 Earnings: What's in Store?
09:46am, Monday, 10'th May 2021
Schrodinger's (SDGR) first-quarter results are likely to reflect benefits from collaborations.
Schrödinger to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
08:01am, Tuesday, 04'th May 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will participate in the Bank of America Securities 2021 Virtual Healthcare Conference.
Schrodinger - Continued Volatility, Continued Promise
03:08am, Monday, 03'rd May 2021
Schrodinger has done well as a company and very well as a stock since the company went public last year. Valuation multiples have expanded a great deal as investors price in the near unlimited potenti
Schrödinger to Host Conference Call to Discuss First Quarter 2021 Financial Results
08:01am, Tuesday, 27'th Apr 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that it will report first quarter 2021 financial results on May 11, 2021.
NEW YORK--(BUSINESS WIRE)---- $SDGR #AACR21--Schrödinger presented new preclinical data from its CDC7 inhibitor program during AACR 21 Annual Virtual Meeting.
Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery
08:01am, Friday, 09'th Apr 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that the company will participate in the BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery.
Schrödinger to Host Webcast in Conjunction with Presentation of Preclinical Data for Its CDC7 Program at Virtual AACR Annual Meeting
08:01am, Tuesday, 30'th Mar 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger will host a webcast to review the preclinical data being presented at the AACR Annual Meeting.
NEW YORK--(BUSINESS WIRE)--Schrödinger will participate in the virtual Credit Suisse 2021 Healthcare Innovators Series on March 23, 2021.
Is There Any Hope Left for Schrodinger Stock?
06:40am, Saturday, 13'th Mar 2021
This drug discovery company's stock just took a major hit.
Schrödinger Announces Preclinical Data for CDC7 Program to Be Presented at AACR Virtual Annual Meeting 2021
04:45pm, Wednesday, 10'th Mar 2021
NEW YORK--(BUSINESS WIRE)---- $SDGR #AACR21--Schrödinger announced that preclinical data from its CDC7 program will be presented at the AACR Annual Meeting.
Schrödinger, Inc. (SDGR) CEO Ramy Farid on Q4 2020 Results - Earnings Call Transcript
12:46pm, Thursday, 04'th Mar 2021
Schrödinger, Inc. (SDGR) CEO Ramy Farid on Q4 2020 Results - Earnings Call Transcript
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2020 and Provides Outlook for 2021
07:01am, Thursday, 04'th Mar 2021
NEW YORK--(BUSINESS WIRE)---- $SDGR #earnings--Schrödinger today reported financial results for the fourth quarter and full year 2020.
Schrödinger to Present at the H.C. Wainwright Global Life Sciences Conference
08:01am, Monday, 01'st Mar 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that management will provide a corporate overview during the H.C. Wainwright Global Life Sciences Conference.
Schrödinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives
08:01am, Thursday, 25'th Feb 2021
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it has expanded its collaboration with Google Cloud.
Bill Gates' Trust Sold Alibaba, Uber, and Apple Stock. Here's What It Bought.
07:00am, Saturday, 20'th Feb 2021
The Bill & Melinda Gates Foundation Trust closed its Alibaba position as Jack Ma retreated from public view. Instead, Gates boosted holdings in a provider of drug-discovery software.
